These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17483980

  • 1. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 2. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Jan; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 3. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 5. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Dec; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 6. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 8. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Jul; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 9. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S.
    Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 11. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E.
    Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
    Yoshidome K, Takei S, Imanaka H, Maeno N, Ohkawa T, Kawano Y.
    Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
    [Abstract] [Full Text] [Related]

  • 13. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
    Tanaka H, Oki ES, Tsugawa K, Suzuki K, Tsuruga K, Ito E.
    Nephrology (Carlton); 2007 Aug; 12(4):376-9. PubMed ID: 17635753
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children.
    Pediatr Nephrol; 2010 May; 25(5):877-82. PubMed ID: 19902267
    [Abstract] [Full Text] [Related]

  • 15. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T, Igarashi T, Shimizu A, Itoh Y.
    J Nippon Med Sch; 2013 May; 80(5):396-400. PubMed ID: 24189359
    [Abstract] [Full Text] [Related]

  • 16. [Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
    Aihara Y, Ibe M, Mitsuda T, Mori M, Shimizu C, Takahashi Y, Kuriyama T, Yokota S.
    Ryumachi; 1994 Feb; 34(1):64-70. PubMed ID: 8146731
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis.
    Tanaka H, Aizawa T, Endo M.
    Nephrology (Carlton); 2024 Oct 21. PubMed ID: 39429105
    [Abstract] [Full Text] [Related]

  • 18. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
    Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M.
    Pediatr Int; 2006 Apr 21; 48(2):152-7. PubMed ID: 16635174
    [Abstract] [Full Text] [Related]

  • 19. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H.
    Clin Exp Nephrol; 2012 Oct 21; 16(5):760-6. PubMed ID: 22492013
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M.
    Lupus; 2012 Nov 21; 21(13):1444-9. PubMed ID: 22917589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.